Latest On Aptose Biosciences Inc (APTO):
| Date/Time | Type | Description | Signal | Details |
|---|---|---|---|---|
| 2023-05-25 17:47 EST | News | Aptose to sell up to $25M stock in the U.S. | N/A |  |
| 2023-05-09 23:59 EST | News | Aptose Biosciences GAAP EPS of -$0.15 misses by $0.03 | N/A | |
| 2023-05-09 09:30 EST | News | Aptose Biosciences Inc. (APTO) Q1 2023 Earnings Call Transcript | N/A | |
| 2023-03-24 06:47 EST | News | Aptose Biosciences GAAP EPS of -$0.45 beats by $0.01 | N/A | |
| 2023-03-24 06:47 EST | News | Aptose Biosciences Inc. (APTO) Q4 2022 Earnings Call Transcript | N/A | |
| 2023-03-22 23:32 EST | News | Aptose Biosciences Q4 2022 Earnings Preview | N/A | |
| 2023-03-13 10:04 EST | News | RAPT Therapeutics, Repare Therapeutics among biotechs to disclose exposure to Silicon Valley Bank | N/A | |
| 2022-12-13 02:36 EST | News | Aptose Biosciences falls 10% on $50M equity distribution agreement | N/A | |
| 2022-11-07 14:56 EST | News | Aptose Biosciences: Expansion Studies Could Rebuild Investor Interest In This Beaten-Down Biotech | N/A | |
| 2022-11-03 23:09 EST | News | Aptose climbs after early-stage data for blood cancer candidates | N/A | |
| 2022-11-01 22:23 EST | News | Aptose Biosciences GAAP EPS of -$0.11 beats by $0.01 | N/A | |
| 2022-11-01 22:22 EST | News | Aptose Biosciences Inc. (APTO) Q3 2022 Earnings Call Transcript | N/A | |
| 2022-08-03 02:59 EST | News | Aptose Biosciences GAAP EPS of -$0.11 beats by $0.02 | N/A | |
| 2022-08-03 02:59 EST | News | Aptose Biosciences Inc. (APTO) CEO William Rice on Q2 2022 Results - Earnings Call Transcript | N/A | |
| 2022-08-01 22:03 EST | News | Aptose Biosciences Q2 2022 Earnings Preview | N/A | |
| 2022-07-20 03:57 EST | News | Aptose Biosciences Continues To Drift Without Thesis-Changing Data | N/A | |
| 2022-06-27 23:44 EST | News | Aptose names new CFO | N/A | |
| 2022-05-10 01:57 EST | News | Aptose Biosciences GAAP EPS of -$0.12 beats by $0.02 | N/A | |
| 2022-05-10 01:55 EST | News | Aptose Biosciences Inc. (APTO) CEO Dr. William G. Rice on Q1 2022 Results - Earnings Call Transcript | N/A | |
| 2022-05-09 06:17 EST | News | Aptose Biosciences Q1 2022 Earnings Preview | N/A | |
| 2022-05-04 22:46 EST | News | Aptose stock rises as HM43239 gets FDA fast track status to treat blood cancer subtype | N/A | |
| 2022-03-24 03:42 EST | News | Aptose Biosciences Inc. (APTO) CEO Dr. William G. Rice on Q4 2021 Results - Earnings Call Transcript | N/A | |
| 2022-03-24 03:41 EST | News | Aptose Biosciences stock falls 6% as net loss widens Y/Y | N/A | |
| 2022-03-22 16:43 EST | News | Aptose Biosciences Q4 2021 Earnings Preview | N/A | |
| 2022-03-22 16:41 EST | News | Aptose Biosciences GAAP EPS of -$0.27 misses by $0.11 | N/A | |
| 2022-02-02 14:55 EST | News | Aptose Deep In The Doghouse Due To Lack Of Pipeline Progress | N/A | |
| 2022-01-12 00:54 EST | News | Aptose Biosciences (APTO) Investor Presentation - Slideshow | N/A | |
| 2021-12-15 05:52 EST | News | Aptose shares continue drop in fallout from AML data, but Street firms remain bullish | N/A | |
| 2021-12-14 09:59 EST | News | Aptose falls 10% following ASH data on acute myeloid leukemia candidate | N/A | |
| 2021-11-12 16:46 EST | News | Aptose Biosciences Inc.'s (APTO) CEO William Rice on Q3 2021 Results - Earnings Call Transcript | N/A | |
| 2021-11-11 01:06 EST | News | Aptose Biosciences Q3 2021 Earnings Preview | N/A | |
| 2021-11-05 01:04 EST | News | Aptose inks exclusive license agreement with Hanmi Pharmaceutical | N/A | |
| 2021-08-05 21:49 EST | News | Aptose: High Risk, High Reward. Watch Its Phase I Studies | N/A | |
| 2021-08-04 02:40 EST | News | Aptose Biosciences Inc. (APTO) CEO William Rice on Q2 2021 Results - Earnings Call Transcript | N/A | |
| 2021-07-20 19:08 EST | News | Aptose: Cancer Trial Catalyst Ahead At EHA21 | N/A | |
| 2021-07-20 19:08 EST | News | Aptose tumbles on updated early-stage data luxeptinib in blood cancers | N/A | |
| 2021-07-20 19:05 EST | News | Aptose Biosciences (APTO) Presents Corporate Update at EHA 2021 - Slideshow | N/A | |
| 2021-05-05 11:30 EST | News | Aptose Biosciences Inc. (APTO) CEO William Rice on Q1 2021 Results - Earnings Call Transcript | N/A | |
| 2021-04-28 09:32 EST | News | Aptose Biosciences: An Assessment | N/A | |
| 2021-03-26 04:44 EST | News | Aptose Provides An Encouraging Update, But The Road Ahead Is Still Long | N/A | |
| 2021-03-24 14:09 EST | News | Aptose Biosciences Inc. (APTO) CEO William Rice on Q4 2020 Results - Earnings Call Transcript | N/A | |
| 2021-03-24 14:09 EST | News | Aptose Biosciences updates on clinical trial progress | N/A | |
| 2021-03-23 18:57 EST | News | Aptose Biosciences EPS in-line | N/A | |
| 2021-03-18 16:06 EST | Financials | Company financials have been released. | Neutral | |
| 2020-12-13 03:12 EST | Financials | Company financials have been released. | Neutral | |
| 2020-12-08 19:56 EST | News | Aptose Shares Sell Off As The Market Wanted More Than Further Signs And Portents | N/A | |
| 2020-12-07 21:47 EST | News | Aptose Biosciences falls 27% after ASH presentation disappointment | N/A | |
| 2020-11-15 11:12 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-12 17:00 EST | News | Aptose Shares Look Undervalued Ahead Of Value-Driving Efficacy Data | N/A | |
| 2020-11-12 03:09 EST | Financials | Company financials have been released. | Neutral | |
About Aptose Biosciences Inc (APTO):
Aptose Biosciences Inc., a clinical-stage biotechnology company, discovers and develops personalized therapies addressing unmet medical needs in oncology in the United States. Its clinical programs is APTO-253, which is a Phase 1b clinical trial for the treatment of patients with relapsed/refractory blood cancers, including acute myeloid leukemia and high-risk myelodysplastic syndrome. It has an agreement with CrystalGenomics, Inc. to research, develop, and commercialize CG026806, a bioavailable non-covalent small molecule that is in Phase 1a/b clinical trial for the treatment of patients with relapsed/refractory acute myeloid leukemia and various B-cell malignancies. The company also has an agreement with OHM Oncology for the development, manufacture, and commercialization of APL-581 for the treatment of hematologic malignancies, as well as related molecules. The company was formerly known as Lorus Therapeutics Inc. and changed its name to Aptose Biosciences Inc. in August 2014. Aptose Biosciences Inc. was founded in 1986 and is headquartered in Toronto, Canada.
General
- Name Aptose Biosciences Inc
- Symbol APTO
- Type Common Stock
- Exchange NASDAQ
- Currency USD
- Country USA
- SectorHealthcare
- IndustryBiotechnology
- Full Time Employees 31
- Last Split Factor1:12
- Last Split Date2014-10-06
- Fiscal Year EndDecember
- IPO Date2014-10-23
- Gic SectorHealth Care
- Gic GroupPharmaceuticals, Biotechnology & Life Sciences
- Gic IndustryBiotechnology
- Gic SubIndustryBiotechnology
- Web URLhttp://www.aptose.com
View More
Valuation
- Price/Book (Most Recent Quarter) 2.72
View More
Financials
- Most Recent Quarter 2020-09-30
- Return on Assets -36%
- Return on Equity -62%
- Earnings Per Share -$0.59
- Revenue Per Share $0
- Quarterly Earnings Growth 0%
View More
Highlights
- Market Capitalization 335.59 million
- EBITDA -18748000
- Analyst Target Price $4.72
- Book Value Per Share $1.45
View More
Share Statistics
- Shares Outstanding 88.86 million
- Shares Float 69.03 million
- % Held by Insiders 509%
- % Held by Institutions 52.64%
- Shares Short 2.24 million
- Shares Short Prior Month 2.2 million
- Short Ratio 2.17
- Short % of Float 3%
- Short % of Shares Outstanding 3%
View More
Technicals
- Beta 1.13
- 52 Week High $9
- 52 Week Low $3.46
- 50 Day Moving Average 4.18
- 200 Day Moving Average 4.97
View More
Dividends
- Dividend Date N/A
- ExDividend Date N/A
- Dividend Yield 0%
View More
Aptose Biosciences Inc (APTO) Dividend Calendar:
| Ex-Dividend Date | Payment Date | Record Date | Declared Date | Amount |
|---|
Aptose Biosciences Inc (APTO) Earnings History:
Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.
| Quarter Date | Report Date | Actual Revenue | Reported EPS | EPS Estimate | Deviation from Estimate |
|---|---|---|---|---|---|
| 2020-09-30 | 2020-11-10 | $N/A | -$0.15 | -$0.19 | 21.88% |
| 2020-06-30 | 2020-08-04 | $N/A | -$0.21 | -$0.16 | -32.95% |
| 2020-03-31 | 2020-05-05 | $N/A | -$0.15 | -$0.10 | -44.04% |
| 2019-12-31 | 2020-03-10 | $N/A | -$0.13 | -$0.12 | -7.78% |
| 2019-09-30 | 2019-11-05 | $N/A | -$0.12 | -$0.13 | 4.68% |
| 2019-06-30 | 2019-08-06 | $N/A | -$0.13 | -$0.15 | 16.28% |
| 2019-03-31 | 2019-05-07 | $N/A | -$0.14 | -$0.17 | 18.65% |
| 2018-12-31 | 2019-03-12 | $N/A | -$0.15 | -$0.16 | 8.41% |
| 2018-09-30 | 2018-11-06 | $N/A | -$0.16 | -$0.23 | 30.28% |
| 2018-06-30 | 2018-08-07 | $N/A | -$0.30 | -$0.20 | -46.24% |
| 2018-03-31 | 2018-05-10 | $N/A | -$0.23 | -$0.12 | -94.76% |
| 2017-12-31 | 2018-03-27 | $N/A | -$0.12 | -$0.11 | -10.94% |
| 2017-09-30 | 2017-11-14 | $N/A | -$0.11 | -$0.15 | 25.84% |
| 2017-06-30 | 2017-08-08 | $N/A | -$0.12 | -$0.18 | 33.37% |
| 2017-03-31 | 2017-05-11 | $N/A | -$0.19 | ||
| 2016-12-31 | 2017-03-28 | $N/A | -$0.19 | -$0.24 | 19.08% |
| 2016-09-30 | 2016-11-14 | $N/A | -$0.23 | -$0.33 | 29.9% |
| 2016-06-30 | 2016-08-09 | $N/A | -$0.35 | -$0.28 | -23.89% |
| 2016-03-31 | 2016-05-10 | $N/A | -$0.32 | -$0.29 | -13.52% |
| 2015-12-31 | 2016-03-29 | $N/A | -$0.29 | -$0.21 | -38.09% |
| 2015-09-30 | 2015-11-10 | $N/A | -$0.27 | -$0.33 | 18.18% |
| 2015-06-30 | 2015-08-04 | $N/A | -$0.28 | -$0.36 | 22.22% |
| 2015-03-31 | 2015-05-05 | $N/A | -$0.30 | -$0.32 | 6.25% |
| 2014-12-31 | 2015-03-03 | $N/A | -$0.31 | -$0.31 | 0% |
| 2014-06-30 | 2014-07-15 | $N/A | -$0.48 | -$0.22 | -118.18% |
| 2014-03-31 | 2014-04-10 | $N/A | -$0.48 | -$0.77 | 37.66% |
| 2013-12-31 | 2014-01-08 | $N/A | -$0.74 | ||
| 2013-09-30 | 2013-10-16 | $N/A | -$0.30 | ||
| 2013-06-30 | 2013-07-15 | $N/A | -$0.37 | ||
| 2013-03-31 | 2013-04-15 | $N/A | -$0.39 | ||
| 2012-12-31 | 2013-01-14 | $N/A | -$0.46 | ||
| 2012-09-30 | 2012-10-31 | $N/A | -$0.35 | ||
| 2012-06-30 | 2012-07-23 | $N/A | -$0.60 | ||
| 2012-03-31 | 2012-04-12 | $N/A | -$0.57 | ||
| 2011-12-31 | 2012-01-12 | $N/A | -$0.81 | ||
| 2011-09-30 | 2011-11-02 | $N/A | -$0.79 | ||
| 2011-06-30 | 2011-08-26 | $N/A | -$0.87 | ||
| 2011-03-31 | 2011-04-14 | $N/A | -$1.21 | ||
| 2010-12-31 | 2011-01-14 | $N/A | -$1.30 | ||
| 2010-06-30 | 2010-08-30 | $N/A | -$1.35 | ||
| 2010-03-31 | 2010-04-15 | $122476.32 | -$1.54 | ||
| 2009-12-31 | 2010-01-14 | $2878.8 | -$1.65 | ||
| 2009-09-30 | 2009-10-06 | $74831.87 | $12.06 | ||
| 2009-06-30 | 2009-07-27 | $44757.03 | -$2.27 | ||
| 2009-03-31 | 2009-04-14 | $71494.04 | -$2.84 | ||
| 2008-12-31 | 2009-01-14 | $49581.65 | -$2.86 | ||
| 2008-09-30 | 2008-10-09 | $31350.48 | -$3.39 | ||
| 2008-06-30 | 2008-07-21 | $2811.62 | -$7.16 | ||
| 2008-03-31 | 2008-04-14 | $12977.94 | -$6.40 | ||
| 2007-09-30 | 2007-12-28 | $999.9 | -$4.80 | ||
| 2007-06-30 | 2007-08-14 | $24625.88 | -$2.62 | ||
| 2007-03-31 | 2007-04-19 | $37365.72 | -$3.02 | ||
| 2006-09-30 | 2006-12-29 | $20148.93 | -$4.74 | ||
| 2006-06-30 | 2006-07-31 | $6342.88 | -$5.39 | ||
| 2006-03-31 | 2006-04-07 | $12712.25 | -$7.33 | ||
| 2005-12-31 | 2006-01-17 | $4398.7 | -$9.00 | ||
| 2005-09-30 | 2005-10-07 | $5146.68 | -$9.79 | ||
| 2005-06-30 | 2005-07-21 | $841.4 | -$7.77 | ||
| 2005-03-31 | 2005-04-08 | $2391.77 | -$8.98 | ||
| 2004-12-31 | 2005-01-11 | $2432.3 | -$10.00 | ||
| 2004-09-30 | 2004-10-08 | $843.45 | -$9.83 | ||
| 2004-06-30 | 2004-07-22 | $1523.81 | -$12.40 | ||
| 2004-03-31 | 2004-04-23 | $1467.89 | -$13.03 | ||
| 2003-12-31 | 2004-01-29 | $1494.21 | -$9.44 | ||
| 2003-09-30 | 2003-10-10 | $441052.39 | -$12.46 | ||
| 2003-03-31 | 2003-05-31 | $28492.11 | -$10.01 | ||
| 2002-12-31 | 2003-02-28 | $18200.2 | -$6.16 | ||
| 2002-09-30 | 2002-11-30 | $N/A | -$6.28 | ||
| 2002-06-30 | 2002-08-31 | $N/A | -$6.56 | ||
| 2002-03-31 | 2002-05-31 | $N/A | -$5.94 |
Aptose Biosciences Inc (APTO) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
| Date |
|---|
| Research Development |
| Income Before Tax |
| Selling General Administrative |
| Gross Profit |
| Ebit |
| Operating Income |
| Income Tax Expense |
| Total Revenue |
| Cost of Revenue |
| Total Other Income Expense Net |
| Net Income From Continuing Operations |
| Net Income Applicable to Common Shares |
Cash Flow:
| Date |
|---|
| Investments |
| Change to Liabilities |
| Total Cash Flow from Investing Activities |
| Net Borrowings |
| Total Cash Flow from Financial Activities |
| Change to Operating Activities |
| Change in Cash |
| Total Cash from Operating Activities |
| Depreciation |
| Other Cash Flow from Investing Activities |
| Change to Inventory |
| Change to Account Receivables |
| Other Cash Flow from Financing Activities |
| Change to Net Income |
| Capital Expenditures |
Balance Sheet:
| Date |
|---|
| Total Liabailities |
| Total Stockholder Equity |
| Other Current Liabilities |
| Total Assets |
| Common Stock |
| Other Current Assets |
| Retained Earnings |
| Other Liabilities |
| Other Assets |
| Cash |
| Total Current Liabilities |
| Other Stockholder Equity |
| Property, Plant & Equipment |
| Total Current Assets |
| Long Term Investments |
| Net Tangible Assets |
| Short Term Investments |
| Long Term Debt |
| Inventory |
| Accounts Payable |
Aptose Biosciences Inc (APTO) Chart:
Aptose Biosciences Inc (APTO) News:
Below you will find a list of latest news for Aptose Biosciences Inc (APTO) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
Aptose Biosciences Inc (APTO) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
| Expiration Date | Strike | Last Price | Type | Volume | Open Interest | Implied Volatility | In The Money | Change | Change Percent |
|---|
Latest APTO Trades:
| Date | Shares | Price |
|---|---|---|
| Jun 13, 2022 7:55 PM EST | 100 | $0.8214 |
| Jun 13, 2022 7:55 PM EST | 91 | $0.8214 |
| Jun 13, 2022 7:55 PM EST | 100 | $0.8214 |
| Jun 13, 2022 7:55 PM EST | 96 | $0.8214 |
| Jun 13, 2022 7:57 PM EST | 2 | $0.8233 |
Aptose Biosciences Inc (APTO) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
| Date | Form Type | Form Name | Link |
|---|---|---|---|
| 2020-07-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/882361/000156761920012894/0001567619-20-012894-index.htm |
| 2019-04-04 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/882361/000000000019006538/0000000000-19-006538-index.htm |
| 2019-04-12 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/882361/000000000019007086/0000000000-19-007086-index.htm |
| 2020-01-06 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/882361/000000000020000087/0000000000-20-000087-index.htm |
| 2019-06-03 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/882361/000091228219000051/0000912282-19-000051-index.htm |
| 2019-12-05 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/882361/000091228219000153/0000912282-19-000153-index.htm |
| 2020-01-07 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/882361/000091228220000004/0000912282-20-000004-index.htm |
| 2020-02-14 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/882361/000108514620000753/0001085146-20-000753-index.htm |
| 2020-02-14 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/882361/000110465920021212/0001104659-20-021212-index.htm |
| 2019-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/882361/000110580619000006/0001105806-19-000006-index.htm |
| 2019-01-02 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/882361/000117184319000005/0001171843-19-000005-index.htm |
| 2019-01-03 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/882361/000117184319000060/0001171843-19-000060-index.htm |
| 2019-02-25 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/882361/000117184319001169/0001171843-19-001169-index.htm |
| 2019-02-28 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/882361/000117184319001394/0001171843-19-001394-index.htm |
| 2019-03-04 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/882361/000117184319001440/0001171843-19-001440-index.htm |
| 2019-03-12 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/882361/000117184319001661/0001171843-19-001661-index.htm |
| 2019-03-12 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/882361/000117184319001666/0001171843-19-001666-index.htm |
| 2019-03-12 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/882361/000117184319001667/0001171843-19-001667-index.htm |
| 2019-03-12 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/882361/000117184319001669/0001171843-19-001669-index.htm |
| 2019-03-12 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/882361/000117184319001671/0001171843-19-001671-index.htm |
| 2019-03-12 | S-3 | Registration statement under Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/882361/000117184319001672/0001171843-19-001672-index.htm |
| 2019-03-25 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/882361/000117184319001938/0001171843-19-001938-index.htm |
| 2019-03-26 | 10-K/A | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/882361/000117184319001984/0001171843-19-001984-index.htm |
| 2019-04-01 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/882361/000117184319002105/0001171843-19-002105-index.htm |
| 2019-04-09 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/882361/000117184319002315/0001171843-19-002315-index.htm |
| 2019-04-12 | PRE 14A | Other preliminary proxy statements | https://www.sec.gov/Archives/edgar/data/882361/000117184319002371/0001171843-19-002371-index.htm |
| 2019-04-12 | 10-K/A | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/882361/000117184319002382/0001171843-19-002382-index.htm |
| 2019-04-22 | 10-K/A | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/882361/000117184319002540/0001171843-19-002540-index.htm |
| 2019-04-22 | S-3/A | Registration statement under Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/882361/000117184319002542/0001171843-19-002542-index.htm |
| 2019-04-23 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/882361/000117184319002558/0001171843-19-002558-index.htm |
| 2019-04-26 | 424B2 | Prospectus [Rule 424(b)(2)] | https://www.sec.gov/Archives/edgar/data/882361/000117184319002668/0001171843-19-002668-index.htm |
| 2019-05-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/882361/000117184319003068/0001171843-19-003068-index.htm |
| 2019-05-07 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/882361/000117184319003072/0001171843-19-003072-index.htm |
| 2019-05-08 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/882361/000117184319003129/0001171843-19-003129-index.htm |
| 2019-05-13 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/882361/000117184319003276/0001171843-19-003276-index.htm |
| 2019-05-16 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/882361/000117184319003411/0001171843-19-003411-index.htm |
| 2019-05-28 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/882361/000117184319003622/0001171843-19-003622-index.htm |
| 2019-05-29 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/882361/000117184319003678/0001171843-19-003678-index.htm |
| 2019-05-30 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/882361/000117184319003693/0001171843-19-003693-index.htm |
| 2019-06-03 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/882361/000117184319003766/0001171843-19-003766-index.htm |
| 2019-06-03 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/882361/000117184319003767/0001171843-19-003767-index.htm |
| 2019-06-05 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/882361/000117184319003835/0001171843-19-003835-index.htm |
| 2019-06-14 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/882361/000117184319003995/0001171843-19-003995-index.htm |
| 2019-07-16 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/882361/000117184319004600/0001171843-19-004600-index.htm |
| 2019-08-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/882361/000117184319005204/0001171843-19-005204-index.htm |
| 2019-08-06 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/882361/000117184319005214/0001171843-19-005214-index.htm |
| 2019-10-10 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/882361/000117184319006440/0001171843-19-006440-index.htm |
| 2019-10-22 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/882361/000117184319006658/0001171843-19-006658-index.htm |
| 2019-11-05 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/882361/000117184319007179/0001171843-19-007179-index.htm |
| 2019-11-05 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/882361/000117184319007194/0001171843-19-007194-index.htm |
| 2019-11-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/882361/000117184319007220/0001171843-19-007220-index.htm |
| 2019-12-09 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/882361/000117184319008008/0001171843-19-008008-index.htm |
| 2019-12-09 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/882361/000117184319008014/0001171843-19-008014-index.htm |
| 2019-12-16 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/882361/000117184319008150/0001171843-19-008150-index.htm |
| 2019-12-19 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/882361/000117184319008241/0001171843-19-008241-index.htm |
| 2020-01-29 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/882361/000117184320000562/0001171843-20-000562-index.htm |
| 2020-03-10 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/882361/000117184320001613/0001171843-20-001613-index.htm |
| 2020-03-10 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/882361/000117184320001617/0001171843-20-001617-index.htm |
| 2020-04-21 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/882361/000117184320002734/0001171843-20-002734-index.htm |
| 2020-04-24 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/882361/000117184320002838/0001171843-20-002838-index.htm |
| 2020-04-24 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/882361/000117184320002870/0001171843-20-002870-index.htm |
| 2020-04-27 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/882361/000117184320002890/0001171843-20-002890-index.htm |
| 2020-05-05 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/882361/000117184320003325/0001171843-20-003325-index.htm |
| 2020-05-14 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/882361/000117184320003710/0001171843-20-003710-index.htm |
| 2020-06-03 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/882361/000117184320004140/0001171843-20-004140-index.htm |
| 2020-06-12 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/882361/000117184320004335/0001171843-20-004335-index.htm |
| 2020-06-29 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/882361/000117184320004594/0001171843-20-004594-index.htm |
| 2020-08-04 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/882361/000117184320005509/0001171843-20-005509-index.htm |
| 2020-08-05 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/882361/000117184320005526/0001171843-20-005526-index.htm |
| 2020-10-19 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/882361/000117184320007083/0001171843-20-007083-index.htm |
| 2020-11-04 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/882361/000117184320007544/0001171843-20-007544-index.htm |
| 2019-01-16 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/882361/000117891319000111/0001178913-19-000111-index.htm |
| 2020-02-04 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/882361/000117891320000268/0001178913-20-000268-index.htm |
| 2019-05-03 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/882361/000119312519136640/0001193125-19-136640-index.htm |
| 2019-05-03 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/882361/000119312519136643/0001193125-19-136643-index.htm |
| 2019-05-13 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/882361/000119312519144493/0001193125-19-144493-index.htm |
| 2019-05-13 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/882361/000119312519144497/0001193125-19-144497-index.htm |
| 2019-05-24 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/882361/000119312519157190/0001193125-19-157190-index.htm |
| 2019-05-24 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/882361/000119312519157198/0001193125-19-157198-index.htm |
| 2019-05-29 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/882361/000119312519159730/0001193125-19-159730-index.htm |
| 2019-05-30 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/882361/000119312519161277/0001193125-19-161277-index.htm |
| 2019-05-30 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/882361/000119312519161286/0001193125-19-161286-index.htm |
| 2019-12-16 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/882361/000119312519315321/0001193125-19-315321-index.htm |
| 2019-12-17 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/882361/000119312519316059/0001193125-19-316059-index.htm |
| 2019-12-18 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/882361/000119312519316451/0001193125-19-316451-index.htm |
| 2019-12-27 | S-3 | Registration statement under Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/882361/000119312519324938/0001193125-19-324938-index.htm |
| 2020-01-09 | 424B2 | Prospectus [Rule 424(b)(2)] | https://www.sec.gov/Archives/edgar/data/882361/000119312520004710/0001193125-20-004710-index.htm |
| 2020-05-05 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/882361/000119312520133810/0001193125-20-133810-index.htm |
| 2020-05-05 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/882361/000119312520133829/0001193125-20-133829-index.htm |
| 2020-07-15 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/882361/000119312520193331/0001193125-20-193331-index.htm |
| 2020-07-15 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/882361/000119312520193349/0001193125-20-193349-index.htm |
| 2020-07-16 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/882361/000119312520193969/0001193125-20-193969-index.htm |
| 2020-07-16 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/882361/000119312520193974/0001193125-20-193974-index.htm |
| 2020-07-30 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/882361/000119312520204150/0001193125-20-204150-index.htm |
| 2019-02-12 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/882361/000119380519000164/0001193805-19-000164-index.htm |
| 2019-12-27 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/882361/000149315219019769/0001493152-19-019769-index.htm |
| 2018-12-21 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/882361/000156761918008557/0001567619-18-008557-index.htm |
| 2018-12-21 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/882361/000156761918008558/0001567619-18-008558-index.htm |
| 2018-12-21 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/882361/000156761918008559/0001567619-18-008559-index.htm |
| 2018-12-21 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/882361/000156761918008560/0001567619-18-008560-index.htm |
| 2018-12-21 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/882361/000156761918008561/0001567619-18-008561-index.htm |
| 2018-12-21 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/882361/000156761918008562/0001567619-18-008562-index.htm |
| 2019-01-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/882361/000156761919000411/0001567619-19-000411-index.htm |
| 2019-01-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/882361/000156761919000413/0001567619-19-000413-index.htm |
| 2019-01-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/882361/000156761919000415/0001567619-19-000415-index.htm |
| 2019-01-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/882361/000156761919000417/0001567619-19-000417-index.htm |
| 2019-01-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/882361/000156761919000419/0001567619-19-000419-index.htm |
| 2019-01-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/882361/000156761919000421/0001567619-19-000421-index.htm |
| 2019-01-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/882361/000156761919000423/0001567619-19-000423-index.htm |
| 2019-01-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/882361/000156761919000425/0001567619-19-000425-index.htm |
| 2019-03-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/882361/000156761919006894/0001567619-19-006894-index.htm |
| 2019-03-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/882361/000156761919006974/0001567619-19-006974-index.htm |
| 2019-03-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/882361/000156761919007289/0001567619-19-007289-index.htm |
| 2019-03-21 | 4/A | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/882361/000156761919007332/0001567619-19-007332-index.htm |
| 2019-04-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/882361/000156761919008981/0001567619-19-008981-index.htm |
| 2019-06-05 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/882361/000156761919012812/0001567619-19-012812-index.htm |
| 2019-06-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/882361/000156761919012814/0001567619-19-012814-index.htm |
| 2019-06-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/882361/000156761919013037/0001567619-19-013037-index.htm |
| 2019-10-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/882361/000156761919020037/0001567619-19-020037-index.htm |
| 2020-01-03 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/882361/000156761920000291/0001567619-20-000291-index.htm |
| 2020-01-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/882361/000156761920000293/0001567619-20-000293-index.htm |
| 2020-02-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/882361/000156761920001972/0001567619-20-001972-index.htm |
| 2020-02-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/882361/000156761920001974/0001567619-20-001974-index.htm |
| 2020-02-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/882361/000156761920001976/0001567619-20-001976-index.htm |
| 2020-02-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/882361/000156761920001978/0001567619-20-001978-index.htm |
| 2020-02-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/882361/000156761920001981/0001567619-20-001981-index.htm |
| 2020-02-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/882361/000156761920001983/0001567619-20-001983-index.htm |
| 2020-02-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/882361/000156761920001985/0001567619-20-001985-index.htm |
| 2020-02-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/882361/000156761920001987/0001567619-20-001987-index.htm |
| 2020-02-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/882361/000156761920001989/0001567619-20-001989-index.htm |
| 2020-02-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/882361/000156761920001991/0001567619-20-001991-index.htm |
| 2020-03-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/882361/000156761920006189/0001567619-20-006189-index.htm |
| 2020-03-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/882361/000156761920006192/0001567619-20-006192-index.htm |
| 2020-03-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/882361/000156761920006195/0001567619-20-006195-index.htm |
| 2020-03-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/882361/000156761920006335/0001567619-20-006335-index.htm |
| 2020-03-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/882361/000156761920006337/0001567619-20-006337-index.htm |
| 2020-03-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/882361/000156761920006339/0001567619-20-006339-index.htm |
| 2020-03-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/882361/000156761920006342/0001567619-20-006342-index.htm |
| 2020-03-13 | 4/A | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/882361/000156761920006343/0001567619-20-006343-index.htm |
| 2020-03-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/882361/000156761920006344/0001567619-20-006344-index.htm |
| 2020-03-13 | 4/A | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/882361/000156761920006345/0001567619-20-006345-index.htm |
| 2020-03-13 | 4/A | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/882361/000156761920006347/0001567619-20-006347-index.htm |
| 2020-03-13 | 4/A | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/882361/000156761920006349/0001567619-20-006349-index.htm |
| 2020-03-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/882361/000156761920006350/0001567619-20-006350-index.htm |
| 2020-03-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/882361/000156761920007018/0001567619-20-007018-index.htm |
| 2020-05-07 | 4/A | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/882361/000156761920009219/0001567619-20-009219-index.htm |
| 2020-05-07 | 4/A | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/882361/000156761920009226/0001567619-20-009226-index.htm |
| 2020-05-07 | 4/A | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/882361/000156761920009229/0001567619-20-009229-index.htm |
| 2020-05-07 | 4/A | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/882361/000156761920009232/0001567619-20-009232-index.htm |
| 2020-06-25 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/882361/000156761920012610/0001567619-20-012610-index.htm |
| 2020-07-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/882361/000156761920012894/0001567619-20-012894-index.htm |
| 2020-07-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/882361/000156761920013185/0001567619-20-013185-index.htm |
| 2020-07-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/882361/000156761920013187/0001567619-20-013187-index.htm |
| 2020-07-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/882361/000156761920013189/0001567619-20-013189-index.htm |
| 2019-04-25 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/882361/999999999519000828/9999999995-19-000828-index.htm |
| 2020-01-09 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/882361/999999999520000056/9999999995-20-000056-index.htm |
Aptose Biosciences Inc (APTO) Insider Transactions:
Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Aptose Biosciences Inc (APTO). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.Insider Ownership: 509%Institutional Ownership: 5264%
| Transaction Date | Insider Name | Insider Title | Type | Shares Number | Shares Price | Total Transaction | Shares Held After Transaction | Link |
|---|---|---|---|---|---|---|---|---|
| 2020-07-10 | Jotin Marango | Senior VP, Chief Bus. Officer | Sell | 62,835.00 | 6.05 | 380,151.75 | 116,219.00 | https://www.sec.gov/Archives/edgar/data/882361/000156761920013185/0001567619-20-013185-index.htm |
| 2019-03-13 | Gregory K. Chow | Senior VP & CFO | Buy | 10,000.00 | 1.74 | 17,394.00 | 122,014.00 | https://www.sec.gov/Archives/edgar/data/882361/000156761919006894/0001567619-19-006894-index.htm |
| 2019-03-13 | Gregory K. Chow | Senior VP & CFO | Buy | 5,000.00 | 1.79 | 8,928.00 | 127,014.00 | https://www.sec.gov/Archives/edgar/data/882361/000156761919006894/0001567619-19-006894-index.htm |
| 2019-03-19 | ERICH PLATZER | Director | Sell | 15,000.00 | 2.19 | 32,835.00 | 130,000.00 | https://www.sec.gov/Archives/edgar/data/882361/000156761919007289/0001567619-19-007289-index.htm |
| 2019-06-05 | Gregory K. Chow | Senior VP & CFO | Buy | 7,500.00 | 1.84 | 13,815.00 | 134,514.00 | https://www.sec.gov/Archives/edgar/data/882361/000156761919013037/0001567619-19-013037-index.htm |
| 2019-03-19 | ERICH PLATZER | Director | Sell | 5,000.00 | 2.19 | 10,970.00 | 135,000.00 | https://www.sec.gov/Archives/edgar/data/882361/000156761919007289/0001567619-19-007289-index.htm |
| 2019-03-14 | William G. Rice | Chair, President & CEO | Buy | 10,000.00 | 1.90 | 18,993.00 | 143,014.00 | https://www.sec.gov/Archives/edgar/data/882361/000156761919006974/0001567619-19-006974-index.htm |
| 2019-04-18 | William G. Rice | Chair, President & CEO | Buy | 10,000.00 | 1.85 | 18,507.00 | 153,014.00 | https://www.sec.gov/Archives/edgar/data/882361/000156761919008981/0001567619-19-008981-index.htm |
| 2019-10-24 | William G. Rice | Chairman, President & CEO | Buy | 10,000.00 | 1.92 | 19,200.00 | 163,014.00 | https://www.sec.gov/Archives/edgar/data/882361/000156761919020037/0001567619-19-020037-index.htm |
| 2020-07-02 | Jotin Marango | Senior VP, Chief Bus. Officer | Sell | 20,946.00 | 6.34 | 132,793.45 | 179,054.00 | https://www.sec.gov/Archives/edgar/data/882361/000156761920012894/0001567619-20-012894-index.htm |
| 2020-03-10 | Jotin Marango | Senior VP, Chief Bus. Officer | Buy | 120,000.00 | 200,000.00 | https://www.sec.gov/Archives/edgar/data/882361/000156761920006192/0001567619-20-006192-index.htm | ||
| 2020-07-10 | Gregory K. Chow | Executive VP & CFO | Sell | 126,668.00 | 6.05 | 766,341.40 | 232,846.00 | https://www.sec.gov/Archives/edgar/data/882361/000156761920013189/0001567619-20-013189-index.htm |
| 2020-07-10 | William G. Rice | Chair, President & CEO | Sell | 168,891.00 | 6.05 | 1,021,790.55 | 297,523.00 | https://www.sec.gov/Archives/edgar/data/882361/000156761920013187/0001567619-20-013187-index.htm |
| 2020-03-10 | Gregory K. Chow | Executive VP & CFO | Buy | 225,000.00 | 359,514.00 | https://www.sec.gov/Archives/edgar/data/882361/000156761920006195/0001567619-20-006195-index.htm | ||
| 2020-06-24 | Warren Whitehead | Director | Sell | 5,000.00 | 6.78 | 33,900.00 | 40,000.00 | https://www.sec.gov/Archives/edgar/data/882361/000156761920012610/0001567619-20-012610-index.htm |
| 2020-06-23 | Warren Whitehead | Director | Sell | 5,000.00 | 7.17 | 35,850.00 | 45,000.00 | https://www.sec.gov/Archives/edgar/data/882361/000156761920012610/0001567619-20-012610-index.htm |
| 2020-06-24 | Warren Whitehead | Director | Sell | 12,000.00 | 6.73 | 80,760.00 | 45,000.00 | https://www.sec.gov/Archives/edgar/data/882361/000156761920012610/0001567619-20-012610-index.htm |
| 2020-03-10 | William G. Rice | Chair, President & CEO | Buy | 300,000.00 | 463,014.00 | https://www.sec.gov/Archives/edgar/data/882361/000156761920006189/0001567619-20-006189-index.htm | ||
| 2020-03-25 | William G. Rice | Chair, President & CEO | Buy | 3,400.00 | 5.82 | 19,802.96 | 466,414.00 | https://www.sec.gov/Archives/edgar/data/882361/000156761920007018/0001567619-20-007018-index.htm |
| 2020-06-24 | Warren Whitehead | Director | Buy | 5,000.00 | 1.02 | 5,100.00 | 50,000.00 | https://www.sec.gov/Archives/edgar/data/882361/000156761920012610/0001567619-20-012610-index.htm |
| 2020-06-23 | Warren Whitehead | Director | Sell | 13,000.00 | 7.08 | 92,040.00 | 50,000.00 | https://www.sec.gov/Archives/edgar/data/882361/000156761920012610/0001567619-20-012610-index.htm |
| 2020-06-23 | Warren Whitehead | Director | Buy | 1,250.00 | 1.91 | 2,387.50 | 51,250.00 | https://www.sec.gov/Archives/edgar/data/882361/000156761920012610/0001567619-20-012610-index.htm |
| 2020-06-23 | Warren Whitehead | Director | Buy | 500.00 | 1.60 | 800.00 | 51,750.00 | https://www.sec.gov/Archives/edgar/data/882361/000156761920012610/0001567619-20-012610-index.htm |
| 2020-06-23 | Warren Whitehead | Director | Buy | 1,250.00 | 4.22 | 5,275.00 | 53,000.00 | https://www.sec.gov/Archives/edgar/data/882361/000156761920012610/0001567619-20-012610-index.htm |
| 2020-06-24 | Warren Whitehead | Director | Buy | 7,000.00 | 2.60 | 18,200.00 | 57,000.00 | https://www.sec.gov/Archives/edgar/data/882361/000156761920012610/0001567619-20-012610-index.htm |
| 2020-06-23 | Warren Whitehead | Director | Buy | 10,000.00 | 1.12 | 11,200.00 | 63,000.00 | https://www.sec.gov/Archives/edgar/data/882361/000156761920012610/0001567619-20-012610-index.htm |
| 2019-06-03 | Jotin Marango | Senior VP, Chief Bus. Officer | Buy | 80,000.00 | 80,000.00 | https://www.sec.gov/Archives/edgar/data/882361/000156761919012814/0001567619-19-012814-index.htm |